Position in ROIV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$629,799,555
+$181,430,375 QoQ
Shares Held
17,795,975
+9.9% QoQ
Ownership
2.46%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#8
of 494 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 14%
Shared 0%
None 86%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STATE STREET CORP holds $36,552,510,511 across 411 Biotechnology names. ROIV ranks #9 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,871,459 | $5,896,909,829 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,834,688 | $3,014,621,355 | |
| 3 | INCY |
Incyte Corp
|
9,722,336 | $1,102,124,008 | |
| 4 | MRNA |
Moderna, Inc.
|
15,726,193 | $1,101,305,295 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,555,689 | $1,070,369,059 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
4,897,051 | $917,119,711 | |
| 7 | RPRX |
Royalty Pharma plc
|
12,338,229 | $691,804,500 | |
| 8 | INSM |
INSMED Inc
|
6,052,174 | $645,282,791 |
All Filings in ROIV
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $629,799,555 | 17,795,975 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $448,369,180 | 16,186,613 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $376,743,790 | 17,361,465 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $282,933,178 | 18,700,144 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $222,847,119 | 19,773,480 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $190,314,078 | 18,861,653 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $246,084,252 | 20,801,712 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $225,736,813 | 19,561,249 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $194,939,212 | 18,442,688 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $180,794,032 | 17,153,134 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $154,158,904 | 13,727,418 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $120,546,850 | 10,320,792 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $96,101,671 | 9,533,896 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $59,283,185 | 8,032,952 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $28,021,265 | 3,507,042 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $2,914,521 | 905,131 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $4,464,407 | 1,096,906 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,212,655 | 447,906 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,941,344 | 291,800 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||